Femasys Inc. (FEMY)
FEMY trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1339005/000114036126012375/0001140361-26-012375-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | FEMY on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001339005 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.3M |
| Net income | -$18.6M |
| Operating income | -$17.6M |
| Net margin | -812.3% |
| Operating margin | -767.0% |
| Revenue growth | +40.8% |
| Cash | $9.3M |
| Total assets | $20.7M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 4.8× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-13 |
| Cash and burn | $1.4M cash; operating cash flow -$4.4M a quarter. | Report 2026-06-30 |
| Shares outstanding | 8,656,277 (2026-11-12); 58,479,824 a year earlier; 21,649,623 three years earlier. 1y figure adjusted for split (1-for-20 overall); 3y figure adjusted for split (1-for-20 overall). | Cover page 2026-11-12 |
| Reverse splits, 3 years | 1; latest 1-for-20 on 2026-06-08 | Source 2026-06-08 |
| Shelf and offerings, 12 months | 2 S-3/F-3 shelf filings; 0 424B5 takedowns | Latest 2026-09-03 |
| Exchange deficiency notices, 12 months | 1 (8-K item 3.01) | 8-K 2026-01-15 |
| Auditor | KPMG LLP, Atlanta, Georgia, United States | PCAOB Form AP 2026-04-28 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $74K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $332K | -$4.5M | -$3.9M | $1.4M | $3.5M | $2.3M | 10-Q 2026-08-14 |
| Q1 2026 2026-03-31 | $425K | $846K | -$4.1M | $5.4M | $3.3M | $2.4M | 10-Q 2026-05-08 |
| Q4 2025 2025-12-31 | $813K | -$4.0M | -$4.2M | $9.3M | $3.2M | $2.3M | 10-K 2026-03-31 |
| Q3 2025 2025-09-30 | $729K | -$4.2M | -$5.4M | $4.6M | $276K | $2.1M | 10-Q 2025-11-14 |
| Q2 2025 2025-06-30 | $409K | -$4.6M | -$4.4M | $3.2M | $6.1M | $1.9M | 10-Q 2026-08-14 |
| Q1 2025 2025-03-31 | $341K | -$5.9M | -$4.8M | $3.8M | $5.8M | $1.7M | 10-Q 2026-05-08 |
| Q4 2024 2024-12-31 | $582K | -$5.1M | -$5.1M | $3.5M | $10.8M | $1.6M | 10-K 2026-03-31 |
| Q3 2024 2024-09-30 | $555K | -$5.4M | -$5.5M | $7.6M | No debt tags | $1.3M | 10-Q 2025-11-14 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-09-29 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-11-13 |
| Latest current report | 8-K | 2026-11-13 |
| Latest proxy | DEF 14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 346 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +3.6% |
| 1 month | -19.3% |
| 3 months | -38.0% |
| Year to date | -87.7% |
| 1 year | -91.4% |
| From 52-week high | -93.0% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SINT | SiNtx Technologies Inc. | $1.34 | -1.11% | $10.1M |
| DRIO | DarioHealth Corp. | $1.15 | -8.73% | $13.0M |
| GUTS | Fractyl Health Inc. | $0.9918 | +9.76% | $13.2M |
| PLSM | Pulsenmore Ltd. | $1.41 | +2.17% | $9.2M |
| PAVM | PAVmed Inc. | $1.75 | +7.36% | $14.0M |
| AEMD | Aethlon Medical Inc. | $5.01 | -5.29% | $8.1M |
| CTSO | Cytosorbents Corporation | $4.85 | -0.41% | $15.3M |
| SNWV | SANUWAVE Health Inc. | $1.81 | -0.55% | $15.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier